These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22161420)

  • 21. Coenzyme Q10: a review of its promise as a neuroprotectant.
    Young AJ; Johnson S; Steffens DC; Doraiswamy PM
    CNS Spectr; 2007 Jan; 12(1):62-8. PubMed ID: 17192765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pergolide for levodopa-induced complications in Parkinson's disease.
    Clarke C E; Speller J M
    Cochrane Database Syst Rev; 2000; (2):CD000235. PubMed ID: 10796704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amantadine in Parkinson's disease.
    Crosby N; Deane KH; Clarke CE
    Cochrane Database Syst Rev; 2003; 2003(1):CD003468. PubMed ID: 12535476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease.
    Jankovic J; Hunter C
    Parkinsonism Relat Disord; 2002 Mar; 8(4):271-6. PubMed ID: 12039422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapies for depression in Parkinson's disease.
    Shabnam GN; Th C; Kho D; H R; Ce C
    Cochrane Database Syst Rev; 2003; (3):CD003465. PubMed ID: 12917968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupational therapy for patients with Parkinson's disease.
    Deane KH; Ellis-Hill C; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (3):CD002813. PubMed ID: 11687028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Q10 therapy in patients with idiopathic Parkinson's disease.
    Strijks E; Kremer HP; Horstink MW
    Mol Aspects Med; 1997; 18 Suppl():S237-40. PubMed ID: 9266528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson's disease rat model.
    Park HW; Park CG; Park M; Lee SH; Park HR; Lim J; Paek SH; Choy YB
    Sci Rep; 2020 Jun; 10(1):9572. PubMed ID: 32533070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M
    Pharmacol Res; 2019 Oct; 148():104290. PubMed ID: 31185284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
    Parashos SA; Luo S; Biglan KM; Bodis-Wollner I; He B; Liang GS; Ross GW; Tilley BC; Shulman LM;
    JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blocker therapy for tremor in Parkinson's disease.
    Crosby NJ; Deane KH; Clarke CE
    Cochrane Database Syst Rev; 2003; 2003(1):CD003361. PubMed ID: 12535472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.
    Huntington Study Group
    Neurology; 2001 Aug; 57(3):397-404. PubMed ID: 11502903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ
    J Am Heart Assoc; 2018 Oct; 7(19):e009835. PubMed ID: 30371340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL
    Kardiologiia; 2022 Jun; 62(6):3-14. PubMed ID: 35834336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.
    Elble RJ; Suchowersky O; Shaftman S; Weiner WJ; Huang P; Tilley B;
    Mov Disord; 2010 Jun; 25(8):1082-6. PubMed ID: 20131372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Speech and language therapy for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials.
    Shan CS; Zhang HF; Xu QQ; Shi YH; Wang Y; Li Y; Lin Y; Zheng GQ
    Front Aging Neurosci; 2018; 10():349. PubMed ID: 30467472
    [No Abstract]   [Full Text] [Related]  

  • 40. A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.
    Xu Y; Yang G; Zuo X; Gao J; Jia H; Han E; Liu J; Wang Y; Yan H
    Int Urol Nephrol; 2022 Jan; 54(1):173-184. PubMed ID: 33782820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.